Personalized ß-lactam dosing in patients with coronavirus disease 2019 (COVID-19) and pneumonia: A retrospective analysis on pharmacokinetics and pharmacokinetic target attainment

Pathophysiological changes are important risk factors for critically ill patients with pneumonia manifesting sub-therapeutic antibiotic exposures during empirical treatment. The effect of coronavirus disease 2019 (COVID-19) on antibiotic dosing requirements is uncertain. We aimed to determine the ef...

Descripción completa

Detalles Bibliográficos
Autores principales: Chiriac, Ute, Frey, Otto R., Roehr, Anka C., Koeberer, Andreas, Gronau, Patrick, Fuchs, Thomas, Roberts, Jason A., Brinkmann, Alexander
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2021
Materias:
4900
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8183774/
https://www.ncbi.nlm.nih.gov/pubmed/34087915
http://dx.doi.org/10.1097/MD.0000000000026253

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8183774/
https://www.ncbi.nlm.nih.gov/pubmed/34087915
http://dx.doi.org/10.1097/MD.0000000000026253

Ejemplares similares